Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
Premium Sponsors

BVI

Share

Shervin Korangy

President and Chief Executive Officer

csm_BVI_PL_profile_Shervin_Korangy_high_res_efa5812938.webp

How is BVI working to address the greatest unmet needs in the field?

In many parts of the world, preventable blindness as a result of cataracts, retinal disease or glaucoma is surprisingly common and unsurprisingly debilitating. Procedures have come a long way, but even in the developed world, there is still a lot of room for improvement of care and treatment options. At BVI, we are building a business that ensures it can adapt and specialize to the needs of each market. Certain markets are more open to premium technologies, while others can’t afford them. Having dealt with multinational companies throughout my career, I realize a company becomes less effective when it employs a “one-size-fits-all” mentality. For example, many multinationals refer to Europe as one market when, in fact, each country’s local healthcare system dictates a completely different product portfolio. By maintaining that focus, our speed and responsiveness to customers will outshine.

What is the most exciting project BVI is working on?

I would point to two key themes we think about in our company. Firstly, the USA has traditionally been one or two generations behind Europe for many innovative ophthalmic technologies, including IOLs – mainly because of our differing regulatory pathways. We are actively addressing an acceleration of our product presence in the US market. It is a massive undertaking, but once we bridge the gap, American surgeons and patients will benefit from European innovations. Secondly, we believe technology will continue to shape the way the industry delivers products and services to customers. We believe that technology will make the customer user experience with BVI materially enhanced, so it is cleaner, smoother, and more seamless. We are investing heavily in this aspect.

What should we expect from BVI overthe next five years?

Five months is a long time in our world – let alone five years. I have been at BVI for a short time, just three years, but during this period we have tripled the size of our business and expanded our product range significantly. We are currently well underway through a transformation from a trusted instrument supplier to the fastest-growing, comprehensive ophthalmology company with a sharp focus on our associates, our customers, and our patients. In the coming years, we will be bringing more product launches and innovation to market than any other company out there. We will also continue to develop our internal talent, and attract the best recruits in the industry. Keep watching our transformation – and join the BVI family, if you want to be part of something special.


False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: